Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Tsukasa Fujimoto"'
Autor:
Hiro Takahashi, Shin Kanamasa, Shuichi Fukuyoshi, Mitsuyasu Okabe, Kenji Satou, Masataka Murase, Anna Takahashi, Tomoyuki Minami, Tsukasa Fujimoto, Enoch Y. Park
Publikováno v:
Microbiology Resource Announcements
Itaconic acid is an important organic acid used in the chemical industry. Aspergillus terreus strain IFO6365 is one of the highest-yielding itaconic acid-producing wild-type strains. Here, we report the draft genome sequence of IFO6365, enhancing the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb00688365d0908726e4d6b8d54bc431
https://pubmed.ncbi.nlm.nih.gov/32299870
https://pubmed.ncbi.nlm.nih.gov/32299870
Autor:
Kenji Satou, Tomoyuki Minami, Mitsuyasu Okabe, Hiro Takahashi, Enoch Y. Park, Tsukasa Fujimoto, Shuichi Fukuyoshi, Masataka Murase, Akifumi Oda, Shin Kanamasa, Anna Takahashi
Publikováno v:
Microbiology Resource Announcements
Itaconic acid is an important organic acid used in the chemical industry. Aspergillus terreus strain TN-484 is a high-itaconic-acid-productivity mutant derived from strain IFO6365. Here, we report the draft genome sequence of strain TN-484, advancing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b14770ba3691ed85c9602031b373a797
https://doi.org/10.1128/mra.01170-19
https://doi.org/10.1128/mra.01170-19
Autor:
Masataka Murase, Akifumi Oda, Hiro Takahashi, Tsukasa Fujimoto, Daiki Yamaguchi, Chiyoko Machida, Kenji Satou, Shin Kanamasa, Shuichi Fukuyoshi, Anna Takahashi
Publikováno v:
Microbiology Resource Announcements
Saccharomyces cerevisiae strain Pf-1 is a yeast isolated from Prunus mume; it potentially can be used to produce wine and traditional Japanese sake. Here, we report the draft genome sequence of this strain. The genomic information will provide a deep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24b8bb855ef093c7d7c7cf351b12bd72
https://pubmed.ncbi.nlm.nih.gov/31727710
https://pubmed.ncbi.nlm.nih.gov/31727710
Autor:
Toshitsugu Sugimoto, Emma Sasaki, Satoshi Soen, Hiroaki Ohishi, Teruki Sone, Tsukasa Fujimoto, Sakae Tanaka, Hiroshi Hagino, Hideaki Kishimoto
Publikováno v:
Journal of bone and mineral metabolism. 38(1)
Absorption of oral immediate-release (IR) risedronate tablets is reduced by food intake, thus a delayed-release (DR) tablet has been developed to overcome the necessity of taking IR tablets under fasting conditions. This randomized, double-blind, pha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc174708260f217ba1f5a257ae8f4f9d
https://pubmed.ncbi.nlm.nih.gov/31420748
https://pubmed.ncbi.nlm.nih.gov/31420748
Autor:
Tsukasa Fujimoto, Kiyofumi Sasai, Shinzaburo Noguchi, Junichi Kurebayashi, Hirotaka Iwase, Eiichi Shiba, Hiroko Yamashita, Yasuo Ohashi
Publikováno v:
Breast Cancer (Tokyo, Japan)
Background Luteinizing hormone-releasing hormone (LH-RH) agonists provide effective adjuvant treatment for premenopausal women with endocrine-responsive breast cancer. Here, we investigated appropriate treatment durations of an LH-RH agonist, leupror
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85920dbddf0b820f1560fe2acbd59fff
https://doi.org/10.1007/s12282-015-0593-z
https://doi.org/10.1007/s12282-015-0593-z
Autor:
Yasuo Ohashi, Hirotaka Iwase, Junichi Kurebayashi, Michihiro Yoshida, Tsukasa Fujimoto, Hiroko Yamashita, Shinzaburo Noguchi, Eiichi Shiba
Publikováno v:
Supportive Care in Cancer
Background We conducted an open-label, randomized controlled trial evaluating the appropriate treatment duration of leuprorelin acetate 3-month depot, TAP-144-SR (3M), administered postsurgically every 3 months for 2 years versus 3 or more (up to 5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c288d7c1eb235f5b2c40a59f491acf4c
https://pubmed.ncbi.nlm.nih.gov/29063390
https://pubmed.ncbi.nlm.nih.gov/29063390
Publikováno v:
Breast Cancer (Tokyo, Japan)
Background Leuprorelin acetate, a luteinizing hormone-releasing hormone agonist, is used worldwide in premenopausal women with hormone receptor-positive breast cancer. This study was conducted to assess the non-inferiority of the 6-month depot formul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b09b129aabcc9ca8c751db0b58e2473
https://pubmed.ncbi.nlm.nih.gov/27017207
https://pubmed.ncbi.nlm.nih.gov/27017207
Autor:
Masayuki Noda, Ryuta Suzuki, Akihito Kato, Tsukasa Fujimoto, Michio Fujimoto, Hiroshi Itokawa, Goro Nagashima
Publikováno v:
The Showa University Journal of Medical Sciences. 23:109-114
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::398bdf62e558241a82b872b8c358d53c
https://doi.org/10.15369/sujms.23.109
https://doi.org/10.15369/sujms.23.109
Autor:
Masayuki Noda, Kouji Nakashima, Ryuta Suzuki, Hiroshi Itokawa, Noriyoshi Okamoto, Michio Fujimoto, Masao Moriya, Akihito Kato, Tsukasa Fujimoto
Publikováno v:
Journal of Neuroendovascular Therapy. 3:17-23
●Abstract● Objective: There have been few reports on the association of large or giant aneurysms with congenital absence or hypoplasia of the internal carotid artery (ICA). We present a case of a giant anterior communicating artery aneurysm assoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b2bd3b0598b66759727148a338be024
https://doi.org/10.5797/jnet.3.17
https://doi.org/10.5797/jnet.3.17
Autor:
Takashi Fuse, Hiroshi Itokawa, Noriyoshi Okamoto, Michio Fujimoto, Masayuki Noda, Akihito Kato, Ryuta Suzuki, Kouji Nakashima, Kensuke Tokuyasu, Tsukasa Fujimoto, Masao Moriya
Publikováno v:
Journal of Neuroendovascular Therapy. 3:47-54
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bcbc489431b93d07981586f23964717d
https://doi.org/10.5797/jnet.3.47
https://doi.org/10.5797/jnet.3.47